News
Investment in American manufacturing is on the rise, with pharmaceutical giant Merck recently announcing a landmark $1 billion investment to establish a manufacturing plant in Wilmington, Delaware.
How the president of EMD Serono, Merck KGaA, Darmstadt, Germany’s U.S. arm, is leading the charge to “double down” on new innovation.
A little-known tissue composed of a cluster of immune cells could offer novel insights into the development of neurological disorders. Meninges' immune system changes with age and neurodegeneration.
Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a ...
Merck KGaA's ( ETR:MRK ) recent earnings report didn't offer any surprises, with the shares unchanged over the ...
Pharmaceutical research and development firms in China are increasingly interested in procuring critical supplies known as ...
With the backing of a new special taxing district in De Soto, Oddo Development hopes to break ground on a mixed-housing ...
Phase 1b/2 in MSS CRC shows 19.4-month median OS (mOS) in 10 mg/kg dose cohorts; mOS for 20 mg/kg cohorts has not yet been reached Alignment with FDA on Phase 2 and Phase 3 trial ...
The reach of the med-tech patent wars now includes devices for electroencephalography thanks to a complaint recently filed by Sunnyvale, Calif.-based Ceribell Inc. with the U.S. International Trade ...
The Institute for Deep Tech Innovation (DEEP) at ESMT Berlin and Merck are joining forces to establish a leading innovation ...
Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on ...
XTRA:MRK 1 Year Share Price vs Fair Value Explore Merck KGaA's Fair Values from the Community and select yours ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results